The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Inflammatory arthritis in caspase 1 gene–deficient mice: Contribution of proteinase 3 to caspase 1–independent production of bioactive interleukin‐1β
Open accessAbstract
Objective: Caspase 1, a known cysteine protease, is a critical component of the inflammasome. Both caspase 1 and neutrophil serine proteases such as proteinase 3 (PR3) can process pro–interleukin‐1β (proIL‐1β), a crucial cytokine linked to the pathogenesis of rheumatoid arthritis. This study was undertaken to establish the relative importance of caspase 1 and serine proteases in mouse models of acute and chronic inflammatory arthritis. Methods: Acute and chronic arthritis were induced in caspase 1−/− mice, and the lack of caspase 1 was investigated for its effects on joint swelling, cartilage metabolism, and histopathologic features. In addition, caspase 1 activity was inhibited in mice lacking active cysteine proteases, and the effects of dual blockade of caspase 1 and serine proteases on arthritis severity and histopathologic features were evaluated. Results: Surprisingly, caspase 1−/− mice, in a model of acute (neutrophil‐dominated) arthritis, developed joint swelling to an extent similar to that in wild‐type control mice. Joint fluid concentrations of bioactive IL‐1β were comparable in caspase 1−/− mice and controls. In contrast, induction of chronic arthritis (characterized by minimal numbers of neutrophils) in caspase 1−/− mice led to reduced joint inflammation and less cartilage damage, implying a caspase 1–dependent role in this process. In mice lacking neutrophil serine PR3, inhibition of caspase 1 activity resulted in decreased bioactive IL‐1β concentrations in the synovial tissue and less suppression of chondrocyte anabolic function. In addition, dual blockade of both PR3 and caspase 1 led to protection against cartilage and bone destruction. Conclusion: Caspase 1 deficiency does not affect neutrophil‐dominated joint inflammation, whereas in chronic arthritis, the lack of caspase 1 results in reduced joint inflammation and cartilage destruction. These findings suggest that inhibitors of caspase 1 are not able to interfere with the whole spectrum of IL‐1β production, and therefore such inhibitors may be of therapeutic value only in inflammatory conditions in which limited numbers of neutrophils are present.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Self-citationInterleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme
Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S.-S., & Flavell, R. A. (1995) · Science · doi:10.1126/science.7535475 · Cited by 1,616
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
Sugimoto, K., Ogawa, A., Mizoguchi, E., Shimomura, Y., Andoh, A., Bhan, A. K., Blumberg, R. S., Xavier, R. J., & Mizoguchi, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33194 · Cited by 1,023
Neutrophil serine proteases: specific regulators of inflammation
Pham, C. T. N. (2006) · Nature Reviews Immunology · doi:10.1038/nri1841 · Cited by 1,022
Self-citationOkusawa, S., Gelfand, J. A., Ikejima, T., Connolly, R. J., & Dinarello, C. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113431 · Cited by 983
Self-citationTreatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2196::aid-art15>3.0.co;2-2 · Cited by 981
Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4
Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J. G., Dower, S. K., Sims, J. E., & Mantovani, A. (1993) · Science · doi:10.1126/science.8332913 · Cited by 980
Martinon, F., & Tschopp, J. (2004) · Cell · doi:10.1016/j.cell.2004.05.004 · Cited by 938
Structure and mechanism of interleukin-lβ converting enzyme
Wilson, K. P., Black, J.-A. F., Thomson, J. A., Kim, E. E., Griffith, J. P., Navia, M. A., Murcko, M. A., Chambers, S. P., Aldape, R. A., Raybuck, S. A., et al. (1994) · Nature · doi:10.1038/370270a0 · Cited by 847
Netea, M. G., Nold-Petry, C. A., Nold, M. F., Joosten, L. A. B., Opitz, B., van der Meer, J. H. M., van de Veerdonk, F. L., Ferwerda, G., Heinhuis, B., Devesa, I., et al. (2009) · Blood · doi:10.1182/blood-2008-03-146720 · Cited by 792
Self-citationPerregaux, D., & Gabel, C. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36591-2 · Cited by 758
Aksentijevich, I., Nowak, M., Mallah, M., Chae, J. J., Watford, W. T., Hofmann, S. R., Stein, L., Russo, R., Goldsmith, D., Dent, P., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10688 · Cited by 709
Interleukin-1–Receptor Antagonist in the Muckle–Wells Syndrome
Hawkins, P. N., Lachmann, H. J., & McDermott, M. F. (2003) · New England Journal of Medicine · doi:10.1056/nejm200306193482523 · Cited by 654
NALP1 in Vitiligo-Associated Multiple Autoimmune Disease
Jin, Y., Mailloux, C. M., Gowan, K., Riccardi, S. L., LaBerge, G., Bennett, D. C., Fain, P. R., & Spritz, R. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061592 · Cited by 630
Greten, F. R., Arkan, M. C., Bollrath, J., Hsu, L.-C., Goode, J., Miething, C., Göktuna, S. I., Neuenhahn, M., Fierer, J., Paxian, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.009 · Cited by 616
Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.
Arend, W. P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115453 · Cited by 595
Interleukin‐1β, Interleukin‐18, and the Interleukin‐1β Converting Enzymea
DINARELLO, C. A. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08307.x · Cited by 498
Self-citationBlocking IL-1 in systemic inflammation
Dinarello, C. A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050640 · Cited by 494
Self-citationInterleukin-18 and Interleukin-1β: Two Cytokine Substrates for ICE (Caspase-1)
Fantuzzi, G., & Dinarello, C. A. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020506300324 · Cited by 466
Self-citationJoosten, L. A. B., Helsen, M. M., Saxne, T., van de Loo, F. A. J., Heinegård, D. K., & van den Berg, W. B. (1999) · PubMed · Cited by 441
Self-citationIL-1β-converting enzyme (caspase-1) in intestinal inflammation
Siegmund, B., Lehr, H.-A., Fantuzzi, G., & Dinarello, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231473998 · Cited by 421
Self-citationJoosten, L. A. B., Helsen, M. M. A., Saxne, T., van de Loo, F. A. J., Heinegård, D., & van den Berg, W. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.5049 · Cited by 405
Self-citationDipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo
Pham, C. T. N., & Ley, T. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8627 · Cited by 397
Self-citationLoo, F. A. J. V. D., Joosten, L. A. B., Van Lent, P. L. E. M., Arntz, O. J., & Van Den Berg, W. B. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380204 · Cited by 380
Self-citationAganna, E., Martinon, F., Hawkins, P. N., Ross, J. B., Swan, D. C., Booth, D. R., Lachmann, H. J., Gaudet, R., Woo, P., Feighery, C., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10509 · Cited by 367
Coeshott, C., Ohnemus, C., Pilyavskaya, A., Ross, S., Wieczorek, M., Kroona, H., Leimer, A. H., & Cheronis, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6261 · Cited by 365
Adkison, A. M., Raptis, S. Z., Kelley, D. G., & Pham, C. T. N. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213462 · Cited by 358
Self-citationCritical Roles for Interleukin 1 and Tumor Necrosis Factor α in Antibody-induced Arthritis
Ji, H., Pettit, A., Ohmura, K., Ortiz-Lopez, A., Duchatelle, V., Degott, C., Gravallese, E., Mathis, D., & Benoist, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020439 · Cited by 332
Koenders, M. I., Lubberts, E., Oppers-Walgreen, B., van den Bersselaar, L., Helsen, M. M., Di Padova, F. E., Boots, A. M. H., Gram, H., Joosten, L. A. B., & van den Berg, W. B. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62961-6 · Cited by 310
Self-citationTNF-induced structural joint damage is mediated by IL-1
Zwerina, J., Redlich, K., Polzer, K., Joosten, L., Krönke, G., Distler, J., Hess, A., Pundt, N., Pap, T., Hoffmann, O., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610812104 · Cited by 304
Self-citationGranzyme A is an interleukin 1 beta-converting enzyme.
Irmler, M., Hertig, S., MacDonald, H. R., Sadoul, R., Becherer, J. D., Proudfoot, A., Solari, R., & Tschopp, J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1917 · Cited by 227
Campbell, E. J., Campbell, M. A., & Owen, C. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3366 · Cited by 191
Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1
Nigrovic, P. A., Binstadt, B. A., Monach, P. A., Johnsen, A., Gurish, M., Iwakura, Y., Benoist, C., Mathis, D., & Lee, D. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610852103 · Cited by 179
Alten, R., Gram, H., Joosten, L. A., Berg, W. B. V. D., Sieper, J., Wassenberg, S., Burmester, G., van Riel, P., Diaz-Lorente, M., Bruin, G. J., et al. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2438 · Cited by 170
Self-citationMast Cells Contribute to Autoimmune Inflammatory Arthritis via Their Tryptase/Heparin Complexes
Shin, K., Nigrovic, P. A., Crish, J., Boilard, E., McNeil, H. P., Larabee, K. S., Adachi, R., Gurish, M. F., Gobezie, R., Stevens, R. L., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.647 · Cited by 161
Ku, G., Faust, T., Lauffer, L. L., et al. (1996) · Cytokine · doi:10.1006/cyto.1996.0052 · Cited by 111
Joosten, L. A. B., Abdollahi‐Roodsaz, S., Heuvelmans‐Jacobs, M., Helsen, M. M. A., van den Bersselaar, L. A. M., Oppers‐Walgreen, B., Koenders, M. I., & van den Berg, W. B. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23152 · Cited by 90
Self-citationInterleukin-18 Promotes Joint Inflammation and Induces Interleukin-1-Driven Cartilage Destruction
Joosten, L. A. B., Smeets, R. L., Koenders, M. I., van den Bersselaar, L. A. M., Helsen, M. M. A., Oppers‐Walgreen, B., Lubberts, E., Iwakura, Y., van de Loo, F. A. J., & van den Berg, W. B. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63357-3 · Cited by 86
Self-citationKinoshita, M., Okada, M., Hara, M., Furukawa, Y., & Matsumori, A. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000174797.71708.97 · Cited by 58
Coeshott, C. M., Pilyavskaya, A., Ross, S., Wieczorek, M., Kroona, H., Leimer, A. H., & Cheronis, J. C. (1999) · Cited by 57
van den Broek, M. F., van den Berg, W. B., van de Putte, L. B., & Severijnen, A. J. (1988) · PubMed · Cited by 48
Immune Functions of Proteinase 3
Sugawara, S. (2005) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v25.i5.10 · Cited by 20
Biological assays for interleukin 1 detection
Remvig, L., Vibe-Petersen, J., Svenson, M., Enk, C., & Bendtzen, K. (1991) · Allergy · doi:10.1111/j.1398-9995.1991.tb00544.x · Cited by 8
Cited by
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
Self-citationCytokines in Inflammatory Disease
Kany, S., Vollrath, J. T., & Relja, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236008 · Cited by 1,971
Understanding the mechanism of IL-1β secretion
Lopez-Castejon, G., & Brough, D. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.10.001 · Cited by 1,519
Anti-inflammatory Agents: Present and Future
Dinarello, C. A. (2010) · Cell · doi:10.1016/j.cell.2010.02.043 · Cited by 1,095
Self-citation
Metadata
- Authors
- Joosten, L. A. B., Netea, M. G., Fantuzzi, G., Koenders, M. I., Helsen, M. M. A., Sparrer, H., Pham, C. T., van der Meer, J. W. M., Dinarello, C. A., & van den Berg, W. B.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2009-11-30
- Volume
- 60
- Issue
- 12
- Pages
- 3651-3662
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2096558846
- Cited by
- 296
- References
- 45
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.